Infographics
-
The Importance Of Final Dosage Form For Clinical Trial Material
6/15/2020
In Q4, 2019 ISR asked 100 outsourcers of clinical manufacturing how important it is for the clinical trial material, or IMP, to be in its final dosage form. 44% of respondents said it is very-extremely important for the IMP to be in the final dosage form. Another 47% said it is important.
-
Comfort Level With Data Sharing
3/13/2020
In Q4, 2019, ISR asked 676 outsourcers of manufacturing activities and services about their comfort level regarding data sharing between sponsors and service providers. The graph below shows how each of the data-sharing scenarios panned out, with sponsors being most comfortable with data sharing between their CMO and their own manufacturing department.
-
3 Year Rolling Average – Small Molecule API Customer Loyalty
1/14/2020
In Q4, 2019, ISR asked sponsors who outsource small molecule API to gain insight into customer loyalty. CMO loyalty is computed as an index that consists of overall satisfaction, willingness to recommend, and the likelihood of using the contract manufacturer again. The data below show companies with ten or more responses from recent users for each of the past three years and an industry average derived from all CMOs included in the research; their loyalty component scores are aggregated, averaged and then weighted based on the number of customer interactions.
-
The Most Popular Oral Dosage Form
12/12/2019
In Q2, 2019, ISR asked outsourcers of oral dose manufacturing several questions about the different oral dosage forms in their company’s portfolio. Below are the results for the most popular oral dosage form among respondents, the tablet.
-
Clinical Logistics Service Provider Use by Category
11/11/2019
In Q3, 2019, ISR asked outsourcers of clinical logistics about the types of service providers they use and prefer for clinical logistics. The data show the majority of outsourcers use integrated clinical trial service providers (79%), specialty couriers (71%) and package delivery companies’ healthcare offering (63%).
-
Top Five Oral Dosage Forms By Portfolio Composition
9/12/2019
The top five oral dosage forms account for more than half of products in oral dose portfolios and are: tablets, capsules, controlled release tablets, controlled release capsules, and immediate release tablets.
-
How Do Experience And Capacity Impact Small Molecule API Outsourcing?
7/16/2019
ISR asked 60 outsourcers of small molecule drug substance manufacturing to select from four different reasons that manufacturing may be split between in-house and external resources.
-
Top Five Satisfaction Drivers For Outsourced Oral Dose Manufacturing
6/14/2019
In Q1, 2019, ISR surveyed 102 sponsors who outsource oral dosage form manufacturing to improve our understanding of what influences customers satisfaction.
-
Top Five Satisfaction Drivers For Outsourced Bioprocessing
6/14/2019
ISR surveyed 100 sponsors who outsource bioprocessing to learn what drives CMO satisfaction. Learn why Quality compliance and Technical capabilities and technical service lead satisfaction drivers.
-
Customer Loyalty In Biologic Drug Product Manufacturing
5/15/2019
ISR surveyed sponsors who outsource drug substance manufacturing for biologic compounds to gain insight into their CMO loyalty. ISR computes customer loyalty as an index that consists of overall satisfaction, willingness to recommend, and likelihood to use the CMO again.